Clik here to view.
Corvia Medical lands CE Mark for heart shunt
Corvia Medical said today that it landed CE Mark approval in the European Union for its InterAtrial Shunt device for treating a type of heart failure. The IASD is designed to lower blood pressure in...
View ArticleClik here to view.
Cardinal Health’s Cordis gets back in the drug-eluting stent game with...
Cardinal Health (NYSE:CAH) said today that its Cordis subsidiary is getting back into the drug-eluting stent game via an overseas distribution agreement with Biosensors International (PINK:BSNRY). The...
View ArticleClik here to view.
Median Technologies expands U.S. footprint
France’s Median Technologies (EPA:ALMDT) is consolidating and expanding in Massachusetts, with a new Woburn facility set to open next week. The medical imaging software maker and developer said the...
View ArticleClik here to view.
EndoStim raises $25m Series D for neurostim GERD device
Five months after spiking its plans for an initial public offering, EndoStim said today that it raised a $25 million Series D round for the neurostimulation device it’s developing to treat...
View ArticleClik here to view.
Teleflex prices $400m debt offering
Teleflex (NYSE:TFX) yesterday priced $400 million worth of debt that the maker of surgical tools and equipment plans to use for debt refinancing. The offering, of 4.875% senior notes due in 2026, is...
View ArticleClik here to view.
Health advocates pan research funding bills that would streamline FDA approvals
Measures in the U.S. Congress that would link research funding to moves designed to simplify the approval process for medical devices and drugs is reportedly drawing flak from public health advocates,...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Baxter said to be front-runner in $1.2B race for India’s Gland Pharma
Baxter (NYSE:BAX) is the front-runner in the chase for has emerged as the frontrunner to buy India’s Gland Pharma for as much as $1.2 billion, according to the Economic Times. Hyderabad-based Gland,...
View ArticleClik here to view.
ConforMIS plunges on lowered outlook, search for new CEO
Shares of ConforMIS (NSDQ:CFMS) closed down nearly -8% yesterday and plunged another -40% in after-hours trading, after the medical device company lowered its outlook for the rest of the year and said...
View ArticleClik here to view.
Shareholder sues as Cardiovascular Systems wins extension to settle kickbacks...
A Cardiovascular Systems (NSDQ:CSII) shareholder sued the company in a derivative lawsuit this week, even as the medical device maker won an extension to negotiate a settlement in the very kickbacks...
View ArticleClik here to view.
FDA approves Biofrontera’s drug-device combo for sun-induced skin cancer
Biofrontera (ETR:B8F) shares are up today after the said it won pre-market approval from the FDA for its drug-device combination treatment for a type of sun-induced skin cancer. Leverkusen,...
View ArticleClik here to view.
ITC opens probe of China’s BMC Medical in patent war with ResMed
The U.S. International Trade Commission yesterday opened a probe into BMC Medical‘s importation of sleep apnea devices, as the long-running patent infringement war between the Chinese company and...
View ArticleClik here to view.
Biotelemetry closes $16m VirtualScopics buy
BioTelemetry (NSDQ:BEAT) said yesterday that it closed its $15.5 million acquisition of clinical trial imaging provider VirtualScopics (NSDQ:VSCP), approximately 6 weeks after the deal was 1st...
View ArticleClik here to view.
Wright Medical lands $395m debt placement
Wright Medical (NSDQ:WMGI) today said it raised $395 million in a private placement of debt with a syndicate of institutional investors. The offering, of 2.25% convertible senior notes due in 2021, is...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 13, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Humacyte launches pivotal trial for lab-grown blood vessel
Humacyte is launching a Phase III study of its lab-grown blood vessel Humacyl in 350 patients with end-stage renal disease who are on hemodialysis and don’t qualify for a standard surgical treatment,...
View ArticleClik here to view.
Exthera Medical closes $12 million Series A for Seraph blood infection filter
Martinez, Calif.-based Exthera Medical said it raised a $12 million Series A round following positive tests of its CE-Marked Seraph blood filter in animal studies. The company announced in January...
View ArticleClik here to view.
NeoChord wins FDA nod for mitral valve repair trial
NeoChord said it won an investigational device exemption from the FDA for a clinical trial of its mitral valve repair technology. St. Louis Park, Minn.-based NeoChord said the 20-site study is a...
View ArticleClik here to view.
FDA releases draft guidance on 3D-printed medical devices
The FDA this week issued draft guidance intended to ensure the safe and reliable use of 3D printing for medical devices, a 25-page document that covers everything from design and manufacturing to...
View ArticleClik here to view.
Sensus Healthcare scales back planned IPO
Sensus Healthcare last week said it plans to scale back its planned initial public offering, after tabling the flotation earlier this year. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100...
View Article